CD22/CD19 CAR-T therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD22/CD19 CAR-T therapy, covering 2025-07-30 to 2025-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma [Phase 2]